טוען...
Lethal prostate cancer in the PLCO cancer screening trial
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial randomized men to usual care or annual prostate specific antigen (PSA) screening for six years and digital rectal examination for four years. This trial found no difference between the intervention and usual care arms of the st...
שמור ב:
| הוצא לאור ב: | Eur Urol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4909529/ https://ncbi.nlm.nih.gov/pubmed/27166670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.01.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|